Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
7th Annual Peptides and Oligonucleotides Congress

7th Annual Peptides and Oligonucleotides Congress

Categories

Date of beginning

Monday, 27 April 2020

Duration

3 days

City

London

Country

United Kingdom

Contact

Bradley Copeman

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery and development of oligonucleotide therapeutics, manufacturing and process development. View Agenda: https://bit.ly/2PP4A5V 27 April 2019 – Day One (Kick-off Session)• Turning Challenges to Successes in Peptides Delivery and Formulation 28 April 2020 – Day Two• Peptide Design, Synthesis, Purification and Analytical Technologies• Peptide Manufacturing and Process Development• Oligonucleotide Synthesis, Chemistry, Formulation and Delivery, Process and Analytical Development 29 April 2020 – Day Three• Peptide Therapeutics: Case Studies, Immunogenicity and Novel Disease Treatments• Oligonucleotide Therapeutics and Manufacturing 2020 Live WebinarTargeted, Controlled and Responsive Therapeutic Delivery through the Design of Self-Assembling Peptide HydrogelsPresented by Aline Miller, Professor, University of ManchesterTuesday 14th January 2020 | 02:00 PM GMTRegister: https://bit.ly/2pzwpV9 URLs: Twitter: https://go.evvnt.com/546653-2?pid=5569,LinkedIn: https://go.evvnt.com/546653-3?pid=5569 Price:General Admission: GBP 520.00. Speakers: Gene Liau, Executive Vice President and Head, Research and Preclinical Development, Stoke Therapeutics, Ekkehard Leberer, Senior Director, Sanofi, Matthew Catley, Research Director, MiNA Therapeutics, Jennifer Franklin, Director, CMC Regulatory Affairs, IONIS Pharmaceuticals, Michael Agrez, Chief Executive Officer, InterK Peptide Therapeutics, David Earp, President and Chief Executive Officer, Circle Pharma, Ali Tavassoli, Founder and Chief Scientific Officer, Curve Therapeutics, Olivier Kitten, Founder and Chief Executive Officer, Affilogic, Alex Batchelor, Chief Executive Officer, Orbit Discovery, Els Beirnaert, Chief Executive Officer, Aelin Therapeutics, Andrew Young, Chief Scientific Officer, Intarcia Therapeutics. Time: 8:00 am to 5:00 pm. Venue details: Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith, London, W6 8DR, United Kingdom.